These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30192439)

  • 1. Ectonucleotidase Inhibitory and Redox Activity of Imidazole-Based Organic Salts and Ionic Liquids.
    Boldescu V; Sucman N; Hassan S; Iqbal J; Neamtu M; Lecka J; Sévigny J; Prodius D; Macaev F
    ChemMedChem; 2018 Nov; 13(21):2297-2304. PubMed ID: 30192439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Aminopyridine based amide derivatives as dual inhibitors of tissue non-specific alkaline phosphatase and ecto-5'-nucleotidase with potential anticancer activity.
    Hassan S; Ejaz SA; Saeed A; Shehzad M; Ullah Khan S; Lecka J; Sévigny J; Shabir G; Iqbal J
    Bioorg Chem; 2018 Feb; 76():237-248. PubMed ID: 29197225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids.
    Malhotra SV; Kumar V
    Bioorg Med Chem Lett; 2010 Jan; 20(2):581-5. PubMed ID: 20006501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Approach for Bisphosphonates: Ionic Liquids and Organic Salts from Zoledronic Acid.
    Teixeira S; Santos MM; Ferraz R; Prudêncio C; Fernandes MH; Costa-Rodrigues J; Branco LC
    ChemMedChem; 2019 Oct; 14(20):1767-1770. PubMed ID: 31603287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
    Iqbal J; Saeed A; Raza R; Matin A; Hameed A; Furtmann N; Lecka J; Sévigny J; Bajorath J
    Eur J Med Chem; 2013; 70():685-91. PubMed ID: 24215819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.
    Ghoteimi R; Nguyen VT; Rahimova R; Grosjean F; Cros-Perrial E; Uttaro JP; Mathé C; Chaloin L; Jordheim LP; Peyrottes S
    ChemMedChem; 2019 Aug; 14(15):1431-1443. PubMed ID: 31264794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Classical Organic and Ionic Liquid Cosolvents for Early-Stage Screening in Fragment-Based Inhibitor Design with Unrelated Bacterial and Human Dihydrofolate Reductases.
    Toulouse JL; Abraham SMJ; Kadnikova N; Bastien D; Gauchot V; Schmitzer AR; Pelletier JN
    Assay Drug Dev Technol; 2017; 15(4):141-153. PubMed ID: 28426233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
    Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Profile of the In Vitro Anti-Tumor Activity and In Silico ADME Predictions of Novel Benzothiazole Amide-Functionalized Imidazolium Ionic Liquids.
    Al-Blewi F; Rezki N; Naqvi A; Qutb Uddin H; Al-Sodies S; Messali M; Aouad MR; Bardaweel S
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents.
    Alkahtani HM; Abbas AY; Wang S
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1317-21. PubMed ID: 22225635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ferrocene-based 2-thio-imidazol-4-ones and their copper complexes. Synthesis and cytotoxicity.
    Guk DA; Krasnovskaya OO; Dashkova NS; Skvortsov DA; Rubtsova MP; Dyadchenko VP; Yudina ES; Kosarev MA; Soldatov AV; Shapovalov VV; Semkina AS; Vlasova KY; Pergushov VI; Shafikov RR; Moiseeva AA; Andreeva AV; Andreeva AA; Melnikov MY; Zyk NV; Majouga AG; Beloglazkina EK
    Dalton Trans; 2018 Dec; 47(48):17357-17366. PubMed ID: 30480670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.
    Marton Z; Guillon R; Krimm I; Preeti ; Rahimova R; Egron D; Jordheim LP; Aghajari N; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
    J Med Chem; 2015 Dec; 58(24):9680-96. PubMed ID: 26599519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferative, Morphological and Molecular Docking Studies of New Thiophene Derivatives and their Strategy in Ionic Liquids Immobilized Reactions.
    Mohareb RM; Mukhtar S; Parveen H; Abdelaziz MA; Alwan ES
    Anticancer Agents Med Chem; 2024; 24(9):691-708. PubMed ID: 38321904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic Liquids Immobilized Synthesis of New Xanthenes Derivatives and their Antiproliferative, Molecular Docking, and Morphological Studies.
    Mohareb RM; Ibrahim RA; Al Farouk FO; Alwan ES
    Anticancer Agents Med Chem; 2024; 24(13):990-1008. PubMed ID: 38685778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor activity of novel steroidal imidazolium salt derivatives.
    Deng G; Zhou B; Wang J; Chen Z; Gong L; Gong Y; Wu D; Li Y; Zhang H; Yang X
    Eur J Med Chem; 2019 Apr; 168():232-252. PubMed ID: 30822712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Anticancer Potential of Ionic Liquids.
    Dias AR; Costa-Rodrigues J; Fernandes MH; Ferraz R; Prudêncio C
    ChemMedChem; 2017 Jan; 12(1):11-18. PubMed ID: 27911045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New chiral imidazolium ionic liquids from isomannide.
    Gomes da Silva MD; Pereira MM
    Carbohydr Res; 2011 Feb; 346(2):197-202. PubMed ID: 21185013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
    Abdel-Wahab BF; Awad GE; Badria FA
    Eur J Med Chem; 2011 May; 46(5):1505-11. PubMed ID: 21353349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Activity of Ionic Liquids Based on Ampicillin.
    Ferraz R; Costa-Rodrigues J; Fernandes MH; Santos MM; Marrucho IM; Rebelo LP; Prudêncio C; Noronha JP; Petrovski Ž; Branco LC
    ChemMedChem; 2015 Sep; 10(9):1480-3. PubMed ID: 26190053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylhydrazones: Design, synthesis and investigation of ectonucleotidase (ALP & e5'NT) inhibition activities.
    Younus HA; Hameed A; Mahmood A; Khan MS; Saeed M; Batool F; Asari A; Mohamad H; Pelletier J; Sévigny J; Iqbal J; Al-Rashida M
    Bioorg Chem; 2020 Jul; 100():103827. PubMed ID: 32402802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.